Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4125511 | 0.92 | ADORA2A (0.61) | ADORA2AADORA3 | |
| SCHEMBL4125146 | 0.87 | ADORA2A (0.58) | ADORA2AADORA3 | |
| SCHEMBL1402031 | 0.86 | ADORA2A (0.54) | ADORA2AADORA3 | |
| SCHEMBL1402006 | 0.85 | ADORA2A (0.43) | ADORA2AADORA3 | |
| SCHEMBL1401996 | 0.85 | ADORA2A (0.42) | ADORA2AADORA3 | |
| SCHEMBL242887 | 0.85 | ADORA2A (0.53) | ADORA2AADORA3 | |
| SCHEMBL4110786 | 0.85 | ADORA2A (0.57) | ADORA2AADORA3 | |
| SCHEMBL4559022 | 0.85 | ADORA2A (0.57) | ADORA2AADORA3 | |
| SCHEMBL243109 | 0.84 | ADORA2A (0.63) | ADORA2AADORA3 | |
| SCHEMBL4125508 | 0.84 | ADORA2A (0.52) | ADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099214-A1 | Organic Compounds | NOVARTIS AG | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099214-A1 | Organic Compounds | CYP3A43, OXER1, OPRM1 | ADORA2A 2082/4885ADORA3 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.